Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.080 | 10 | 112974337 | intron variant | A/C;G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 4 | 2013 | 2018 | |||||||
|
0.925 | 0.120 | 10 | 113017965 | intron variant | A/G | snv | 0.55 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2008 | 2009 | |||||||
|
1.000 | 0.040 | 10 | 112971038 | intron variant | A/G | snv | 0.30 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2012 | 2017 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 2 | 2007 | 2009 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 2 | 2013 | 2018 | |||||||
|
10 | 112970444 | intron variant | A/G | snv | 4.2E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
10 | 112970444 | intron variant | A/G | snv | 4.2E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.925 | 0.120 | 10 | 113017965 | intron variant | A/G | snv | 0.55 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.080 | 10 | 113147296 | intron variant | A/G | snv | 0.27 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
10 | 112952224 | intron variant | A/G | snv | 0.57 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.925 | 0.080 | 10 | 113036289 | intron variant | A/G | snv | 0.54 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.080 | 10 | 113036289 | intron variant | A/G | snv | 0.54 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.925 | 0.080 | 10 | 113036289 | intron variant | A/G | snv | 0.54 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2007 | 2007 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.240 | 10 | 113014168 | intron variant | A/G | snv | 0.55 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
1.000 | 0.080 | 10 | 113127459 | intron variant | A/G | snv | 0.70 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.870 | 0.900 | 10 | 2006 | 2020 | ||||||||
|
0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv |
|
0.800 | 1.000 | 4 | 2010 | 2019 | |||||||||
|
0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv |
|
Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2011 | 2016 | ||||||||
|
0.790 | 0.280 | 10 | 112996282 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 2 | 2016 | 2019 |